Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Q32 Bio (QTTB) Operating Expenses (2017 - 2025)

Q32 Bio (QTTB) has 9 years of Operating Expenses data on record, last reported at $7.9 million in Q4 2025.

  • For Q4 2025, Operating Expenses fell 45.9% year-over-year to $7.9 million; the TTM value through Dec 2025 reached $36.8 million, down 44.28%, while the annual FY2025 figure was $36.8 million, 44.28% down from the prior year.
  • Operating Expenses reached $7.9 million in Q4 2025 per QTTB's latest filing, up from $7.6 million in the prior quarter.
  • Across five years, Operating Expenses topped out at $38.4 million in Q1 2022 and bottomed at $7.6 million in Q3 2025.
  • Average Operating Expenses over 5 years is $21.6 million, with a median of $18.4 million recorded in 2024.
  • Peak YoY movement for Operating Expenses: plummeted 73.14% in 2023, then surged 70.98% in 2024.
  • A 5-year view of Operating Expenses shows it stood at $34.4 million in 2021, then increased by 2.52% to $35.3 million in 2022, then plummeted by 68.42% to $11.1 million in 2023, then surged by 30.31% to $14.5 million in 2024, then tumbled by 45.9% to $7.9 million in 2025.
  • Per Business Quant database, its latest 3 readings for Operating Expenses were $7.9 million in Q4 2025, $7.6 million in Q3 2025, and $9.2 million in Q2 2025.